- Home
- OVLY vs LXEO Comparison
OVLY vs LXEO Comparison
Compare OVLY & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OVLY
- LXEO
- Stock Information
- Founded
- OVLY 1990
- LXEO 2017
- Country
- OVLY United States
- LXEO United States
- Employees
- OVLY N/A
- LXEO N/A
- Industry
- OVLY Major Banks
- LXEO
- Sector
- OVLY Finance
- LXEO
- Exchange
- OVLY Nasdaq
- LXEO Nasdaq
- Market Cap
- OVLY 218.4M
- LXEO 257.0M
- IPO Year
- OVLY N/A
- LXEO 2023
- Fundamental
- Price
- OVLY $28.59
- LXEO $4.79
- Analyst Decision
- OVLY
- LXEO Strong Buy
- Analyst Count
- OVLY 0
- LXEO 7
- Target Price
- OVLY N/A
- LXEO $15.29
- AVG Volume (30 Days)
- OVLY 8.8K
- LXEO 299.6K
- Earning Date
- OVLY 07-18-2025
- LXEO 08-14-2025
- Dividend Yield
- OVLY 2.11%
- LXEO N/A
- EPS Growth
- OVLY N/A
- LXEO N/A
- EPS
- OVLY 2.92
- LXEO N/A
- Revenue
- OVLY $79,674,000.00
- LXEO N/A
- Revenue This Year
- OVLY N/A
- LXEO N/A
- Revenue Next Year
- OVLY N/A
- LXEO N/A
- P/E Ratio
- OVLY $9.76
- LXEO N/A
- Revenue Growth
- OVLY 4.08
- LXEO N/A
- 52 Week Low
- OVLY $22.70
- LXEO $1.45
- 52 Week High
- OVLY $32.24
- LXEO $11.96
- Technical
- Relative Strength Index (RSI)
- OVLY 62.48
- LXEO 59.22
- Support Level
- OVLY $27.57
- LXEO $4.50
- Resistance Level
- OVLY $28.98
- LXEO $5.12
- Average True Range (ATR)
- OVLY 0.37
- LXEO 0.33
- MACD
- OVLY 0.10
- LXEO -0.00
- Stochastic Oscillator
- OVLY 75.93
- LXEO 79.06
About OVLY Oak Valley Bancorp (CA)
Oak Valley Bancorp is a bank holding company that operates through Oak Valley Community Bank (the Bank). The Bank offers a complement of business checking and savings accounts for its business customers. The Bank also offers commercial and real estate loans, as well as lines of credit. In addition, the bank provides other services for both individuals and businesses including online banking, remote deposit capture, mobile banking, merchant services, night depository, extended hours, wire transfer of funds, note collection, and automated teller machines in a national network. Its primary source of revenue is net interest income.
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.